Subsequently the same group demonstrated a set of 9 genes including KIAA, TAGAP (T-cell Activation GTPase Activating Protein), and SH2B3 (SH2B Adaptor Protein 3), RGS1 (Regulator of G-protein signaling 1), TAGAP, TNFSF14 (Tumor Necrosis Factor Superfamily member 14), and SH2B3 which could differentiate patients with CeD from controls [89]. The gene discussed is SH2B3; the disease is cranioectodermal dysplasia.